Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.18 earnings per share for the quarter, Zacks reports. Nihon Kohden had a net margin of 7.71% and a return on equity of 15.08%. The company had revenue of $439.11 million during the quarter.
Nihon Kohden Trading Up 5.3%
Shares of NHNKY traded up $0.65 during mid-day trading on Friday, hitting $12.94. 5,045 shares of the company traded hands, compared to its average volume of 5,812. Nihon Kohden has a one year low of $9.86 and a one year high of $20.00. The business has a 50-day moving average of $12.97 and a 200 day moving average of $13.92. The stock has a market capitalization of $2.21 billion, a price-to-earnings ratio of 19.04 and a beta of 0.32.
About Nihon Kohden
(
Get Free Report)
Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.
See Also
Before you consider Nihon Kohden, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nihon Kohden wasn't on the list.
While Nihon Kohden currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
